<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: respiratory syncytial virus</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>One step closer to vaccine for common respiratory disease</title>
   	 <description>Young children and the elderly are especially susceptible to respiratory syncytial virus. The three-dimensional structure of respiratory syncytial virus has been solved by an international team from Finland and Switzerland.</description>
	  <link>http://medicalxpress.com/news/2013-06-closer-vaccine-common-respiratory-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 17 Jun 2013 15:00:21 EST</pubDate>
	 <guid isPermaLink="false">news290695409</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-onestepclose.jpg" width="90" height="90" />
</item>
<item>
     <title>Palivizumab cuts number of days of wheezing in preemies</title>
   	 <description>(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.</description>
	  <link>http://medicalxpress.com/news/2013-05-palivizumab-days-wheezing-preemies.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 09 May 2013 07:40:02 EST</pubDate>
	 <guid isPermaLink="false">news287302721</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/palivizumabc.jpg" width="90" height="90" />
</item>
<item>
     <title>Study offers clues to making vaccine for infant respiratory illness</title>
   	 <description>An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. The findings, by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, define the vulnerable shape of a critical RSV component called the fusion glycoprotein.</description>
	  <link>http://medicalxpress.com/news/2013-04-clues-vaccine-infant-respiratory-illness.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 25 Apr 2013 14:00:18 EST</pubDate>
	 <guid isPermaLink="false">news286116578</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/studyoffersc.jpg" width="90" height="95" />
</item>
<item>
     <title>Research suggests transmission of respiratory viruses in utero</title>
   	 <description>The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's Hospital research published online this week in the journal PLOS ONE.</description>
	  <link>http://medicalxpress.com/news/2013-04-transmission-respiratory-viruses-utero.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 18 Apr 2013 17:31:44 EST</pubDate>
	 <guid isPermaLink="false">news285525096</guid>
	 
</item>
<item>
     <title>Childhood asthma tied to combination of genes and wheezing illness</title>
   	 <description>About 90 percent of children with two copies of a common genetic variation and who wheezed when they caught a cold early in life went on to develop asthma by age 6, according to a study to be published March 28 by the New England Journal of Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-03-childhood-asthma-tied-combination-genes.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 27 Mar 2013 17:00:07 EST</pubDate>
	 <guid isPermaLink="false">news283618892</guid>
	 
</item>
<item>
     <title>Antiviral lipid earns patent: Lipids in lung can inhibit RSV and influenza infections</title>
   	 <description>Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially those caused by influenza and respiratory syncytial virus (RSV). Over the past several years, Dr. Voelker has published several scientific papers describing a naturally occurring lipid in the lungs, POPG (palmitoyl-oleoyl-phosphatidylglycerol), that reduces inflammation and inhibits infection by the influenza virus and RSV. The patent covers POPG and other naturally occurring lipids in the lungs as well as related anionic lipids.</description>
	  <link>http://medicalxpress.com/news/2013-03-antiviral-lipid-patent-lipids-lung.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 05 Mar 2013 11:19:38 EST</pubDate>
	 <guid isPermaLink="false">news281704768</guid>
	 
</item>
<item>
     <title>New study finds maternal diet important predictor of severity for infant RSV</title>
   	 <description>An important predictor of the severity of respiratory syncytial virus (RSV) in infants may be what their mothers ate during pregnancy, according to a Vanderbilt study published in the American Journal of Respiratory and Critical Care Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-03-maternal-diet-important-predictor-severity.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 04 Mar 2013 10:04:32 EST</pubDate>
	 <guid isPermaLink="false">news281613862</guid>
	 
</item>
<item>
     <title>Study reveals clues to childhood respiratory virus</title>
   	 <description>New Vanderbilt-led research published in the Feb. 14 issue of the New England Journal of Medicine has identified the relatively unknown human metapneumovirus (MPV) as the second most common cause of severe bronchiolitis in young children.</description>
	  <link>http://medicalxpress.com/news/2013-02-reveals-clues-childhood-respiratory-virus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 13 Feb 2013 17:10:04 EST</pubDate>
	 <guid isPermaLink="false">news279996748</guid>
	 
</item>
<item>
     <title>Respiratory Syncytial Virus: Study pioneers treatment for viral infection common in children</title>
   	 <description>Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated. In the first year of life, 65 per cent of babies get infected by Respiratory Syncytial Virus (RSV). This causes bronchiolitis, and is thought to kill nearly 200,000 children every year worldwide.</description>
	  <link>http://medicalxpress.com/news/2013-02-respiratory-syncytial-virus-treatment-viral.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 04 Feb 2013 15:00:11 EST</pubDate>
	 <guid isPermaLink="false">news279196354</guid>
	 
</item>
<item>
     <title>Infants with severe RSV disease may be immunosuppressed</title>
   	 <description>Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Infectious Diseases.</description>
	  <link>http://medicalxpress.com/news/2012-12-infants-severe-rsv-disease-immunosuppressed.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 10 Dec 2012 13:12:22 EST</pubDate>
	 <guid isPermaLink="false">news274367529</guid>
	 
</item>
<item>
     <title>RSV study shows potential for vaccine strategies to protect babies</title>
   	 <description>(Medical Xpress)—Research by the University of Warwick indicates that vaccinating families could protect young babies against a common winter virus which can be fatal for infants under six months.</description>
	  <link>http://medicalxpress.com/news/2012-11-rsv-potential-vaccine-strategies-babies.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 15 Nov 2012 07:41:54 EST</pubDate>
	 <guid isPermaLink="false">news272187699</guid>
	 
</item>
<item>
     <title>Inner city infants have different patterns of viral respiratory illness than infants in the suburbs</title>
   	 <description>Children living in low-income urban areas appear especially prone to developing asthma, possibly related to infections they acquire early in life. In a new study in The Journal of Infectious Diseases, available online, researchers from the University of Wisconsin in Madison investigated viral respiratory illnesses and their possible role in the development of asthma in urban versus suburban babies. The differences in viral illness patterns they found provide insights that could help guide the development of new asthma treatments in children.</description>
	  <link>http://medicalxpress.com/news/2012-09-city-infants-patterns-viral-respiratory.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 26 Sep 2012 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news267807835</guid>
	 
</item>
<item>
     <title>Team shows how childhood viral infection leads to increased risk for allergic asthma as adult</title>
   	 <description>(Medical Xpress)—Researchers in the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Pittsburgh School of Medicine have shown in an animal model that a common childhood virus disables the normal immune tolerance transferred from the mother to child through breast milk, leading to increased susceptibility for allergic asthma later in life. Their findings were reported in the online version of Nature Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-09-team-childhood-viral-infection-allergic.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 12 Sep 2012 10:50:01 EST</pubDate>
	 <guid isPermaLink="false">news266662590</guid>
	 
</item>
<item>
     <title>Childhood virus RSV shows promise against adult cancer</title>
   	 <description>RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.</description>
	  <link>http://medicalxpress.com/news/2012-09-childhood-virus-rsv-adult-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 06 Sep 2012 15:06:40 EST</pubDate>
	 <guid isPermaLink="false">news266162787</guid>
	 
</item>
<item>
     <title>Dog-associated house dust protects against respiratory infection linked to asthma</title>
   	 <description>House dust from homes with dogs appears to protect against infection with a common respiratory virus that is associated with the development of asthma in children. Researchers from the University of California, San Francisco, present their findings today at the 2012 General Meeting of the American Society for Microbiology.</description>
	  <link>http://medicalxpress.com/news/2012-06-dog-associated-house-respiratory-infection-linked.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 19 Jun 2012 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news259340253</guid>
	 
</item>
<item>
     <title>Common virus can lead to life-threatening conditions in children</title>
   	 <description>(Medical Xpress) -- Respiratory Syncytial Virus (RSV) is a common virus that infects the lungs and breathing passage ways. Though it may only produce minor cold symptoms in adults, it can lead to serious illness in young children and those with compromised immune systems.</description>
	  <link>http://medicalxpress.com/news/2012-03-common-virus-life-threatening-conditions-children.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 19 Mar 2012 10:10:44 EST</pubDate>
	 <guid isPermaLink="false">news251370638</guid>
	 
</item>
<item>
     <title>Researchers reveal darker side of the common cold</title>
   	 <description>(Medical Xpress) -- Human rhinovirus (HRV), also known as the common cold, can be uncommonly serious for certain children, a study led by a Vanderbilt University Medical Center pediatrician shows.</description>
	  <link>http://medicalxpress.com/news/2012-01-reveal-darker-side-common-cold.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 09 Jan 2012 08:39:34 EST</pubDate>
	 <guid isPermaLink="false">news245320756</guid>
	 
</item>
<item>
     <title>Lipid blocks influenza infection</title>
   	 <description>A natural lipid in the fluid lining the lungs inhibits influenza infections in both cell cultures and mouse models, according to researchers at National Jewish Health. These findings, combined with previous studies demonstrating effectiveness against respiratory syncytial virus, suggest that the molecule, known as POPG, may have broad antiviral activity.</description>
	  <link>http://medicalxpress.com/news/2011-11-lipid-blocks-influenza-infection.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 09 Nov 2011 13:05:52 EST</pubDate>
	 <guid isPermaLink="false">news240066342</guid>
	 
</item>
<item>
     <title>Researchers map pathway of infection for a common, potentially life-threatening respiratory virus</title>
   	 <description>Researchers at the University of Toronto, The Hospital for Sick Children (SickKids), St. Paul's Hospital and the University of British Columbia have identified a new treatment target for a virus that causes severe lung infections and an estimated 10% of common colds.</description>
	  <link>http://medicalxpress.com/news/2011-08-pathway-infection-common-potentially-life-threatening.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 15 Aug 2011 11:08:34 EST</pubDate>
	 <guid isPermaLink="false">news232625297</guid>
	 
</item>
<item>
     <title>An advance for a newborn vaccine approach</title>
   	 <description>(PhysOrg.com) -- Infectious disease is a huge cause of death globally, and is a particular threat to newborns whose immune systems respond poorly to most vaccines. A new approach developed at Children's Hospital Boston, using an adjuvant (an agent to stimulate the immune system) along with the vaccine, shows promise in a study of blood from Gambian infants. Results will appear in the open-access journal PLoS ONE on April 13.</description>
	  <link>http://medicalxpress.com/news/2011-04-advance-newborn-vaccine-approach.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 13 Apr 2011 17:41:26 EST</pubDate>
	 <guid isPermaLink="false">news221935261</guid>
	 
</item>


</channel>
</rss>
